Company Overview
Snapshot
Founded in November 2006 by Adi Plaschkes, ActiVein operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its medical device platform.
Business overview
ActiVein is a medical device company specializing in advanced intravenous (IV) catheters. The company's core product, ActIV, is a dual-action IV catheter designed to facilitate both fluid/medication infusion and needle-free blood withdrawal from a single vein over an extended hospitalization period. This technology aims to replace conventional hospital IV lines, reducing the need for multiple venipunctures. ActiVein also offers ActIV Jr., a solution specifically developed to minimize the pain and distress associated with venipuncture by allowing effortless and painless blood sample collection after initial IV insertion. The company operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is ActiVein's primary product?
- ActiVein's primary product is ActIV, a dual-action intravenous catheter designed to enable both fluid/medication infusion and blood withdrawal from a single vein, replacing standard conventional hospital IV lines.
- When was ActiVein founded?
- ActiVein was founded in November 2006.
- Who is the founder of ActiVein?
- Adi Plaschkes is the Co-Founder and CEO of ActiVein.
- What problem does ActiVein's ActIV Jr. product address?
- ActiVein's ActIV Jr. product aims to reduce the time, pain, and distress associated with venipuncture by allowing needle-free blood sample collection from an IV catheter after initial insertion.
- In which sector does ActiVein primarily operate?
- ActiVein primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.